LRMR Larimar Therapeutics, Inc.

NASDAQ

$2.96

Larimar Therapeutics, Inc. (LRMR) Earnings News

Earnings press releases, previews and reviews for Larimar Therapeutics, Inc. (LRMR), newest first.

Tuesday August 4, 2026 7:00 AM ET

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Thursday May 14, 2026 7:00 AM ET

Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update